CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET

Asthma is characterized by airway inflammation and remodeling and CXCL8 is a CXC chemokine that drives steroid-resistant neutrophilic airway inflammation. We have shown that airway smooth muscle (ASM) cells isolated from asthmatic individuals secrete more CXCL8 than cells from nonasthmatic individuals. Here we investigated chromatin modifications at the CXCL8 promoter in ASM cells from nonasthmatic and asthmatic donors to further understand how CXCL8 is dysregulated in asthma. ASM cells from asthmatic donors had increased histone H3 acetylation, specifically histone H3K18 acetylation, and increased binding of histone acetyltransferase p300 compared with nonasthmatic donors but no differences in CXCL8 DNA methylation. The acetylation reader proteins Brd3 and Brd4 were bound to the CXCL8 promoter and Brd inhibitors inhibited CXCL8 secretion from ASM cells by disrupting Brd4 and RNA polymerase II binding to the CXCL8 promoter. Our results show a novel dysregulation of CXCL8 transcriptional regulation in asthma characterized by a promoter complex that is abnormal in ASM cells isolated from asthmatic donors and can be modulated by Brd inhibitors. Brd inhibitors may provide a new therapeutic strategy for steroid-resistant inflammation.

[1]  S. Knapp,et al.  Targeting bromodomains: epigenetic readers of lysine acetylation , 2014, Nature Reviews Drug Discovery.

[2]  I. Adcock,et al.  Brd4 Is Essential for IL-1β-Induced Inflammation in Human Airway Epithelial Cells , 2014, PloS one.

[3]  B. Rubin,et al.  IL‐33 stimulates CXCL8/IL‐8 secretion in goblet cells but not normally differentiated airway cells , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  Raivo Kolde,et al.  DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns , 2014, Genome Biology.

[5]  A. Salmeron,et al.  BET bromodomain inhibition suppresses TH17-mediated pathology , 2013, The Journal of experimental medicine.

[6]  J. Coppee,et al.  A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection , 2013, Science.

[7]  Saptarsi M. Haldar,et al.  BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure , 2013, Cell.

[8]  A. Andrews,et al.  Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4 , 2013, Biochemistry.

[9]  S. Knapp,et al.  PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains. , 2013, Cancer research.

[10]  S. Zienolddiny,et al.  DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer , 2013, Cancer Immunology, Immunotherapy.

[11]  Yuet-Kin Leung,et al.  Environmental epigenetics and its implication on disease risk and health outcomes. , 2012, ILAR journal.

[12]  J. Greenbaum,et al.  Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors , 2012, Proceedings of the National Academy of Sciences.

[13]  C. Brightling,et al.  Abnormal Histone Methylation Is Responsible for Increased Vascular Endothelial Growth Factor 165a Secretion from Airway Smooth Muscle Cells in Asthma , 2012, The Journal of Immunology.

[14]  P. O'Byrne,et al.  Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  Kevin Struhl,et al.  SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation , 2012, Nature.

[16]  A. Matussek,et al.  DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas , 2011, International Journal of Colorectal Disease.

[17]  S. Robson,et al.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia , 2011, Nature.

[18]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[19]  K. O'Byrne,et al.  Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer , 2011, PloS one.

[20]  Li-Rong Yu,et al.  Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation , 2011, The EMBO journal.

[21]  C. Rice,et al.  Suppression of inflammation by a synthetic histone mimic , 2010, Nature.

[22]  R. Schüle,et al.  Epigenetic regulation of cancer growth by histone demethylases , 2010, International journal of cancer.

[23]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[24]  C. Bruni,et al.  LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes , 2010, BMC Microbiology.

[25]  S. Horvath,et al.  Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Chanez,et al.  Neutrophils in chronic inflammatory airway diseases: can we target them and how? , 2010, European Respiratory Journal.

[27]  C. Brightling,et al.  Airway smooth muscle proliferation and survival is not modulated by mast cells , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  Q. Jöbsis,et al.  Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  C. Brightling,et al.  Human Airway Smooth Muscle Cells from Asthmatic Individuals Have CXCL8 Hypersecretion Due to Increased NF-κB p65, C/EBPβ, and RNA Polymerase II Binding to the CXCL8 Promoter1 , 2009, The Journal of Immunology.

[30]  C. Kroegel.  Global Initiative for Asthma (GINA) guidelines: 15 years of application , 2009, Expert review of clinical immunology.

[31]  M. Drumm,et al.  Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. , 2009, American journal of respiratory cell and molecular biology.

[32]  Loïc Ponger,et al.  CpG dinucleotides and the mutation rate of non-CpG DNA. , 2008, Genome research.

[33]  Yi Zhang,et al.  New Nomenclature for Chromatin-Modifying Enzymes , 2007, Cell.

[34]  P. Bromberg,et al.  COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. , 2007, American journal of respiratory cell and molecular biology.

[35]  Jie Zhu,et al.  Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma , 2007, Thorax.

[36]  L. Mahadevan,et al.  Enhanced histone acetylation and transcription: a dynamic perspective. , 2006, Molecular cell.

[37]  M. Teixeira,et al.  Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[39]  A. Knox,et al.  Differential Regulation of Chemokine Expression by Peroxisome Proliferator-activated Receptor γ Agonists , 2005, Journal of Biological Chemistry.

[40]  A. Knox,et al.  Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. , 2005, The Journal of biological chemistry.

[41]  P. Woll,et al.  Interleukin-8/CXCL8 is a growth factor for human lung cancer cells , 2004, British Journal of Cancer.

[42]  S. Watson,et al.  Matrix metalloproteinase expression and activity in human airway smooth muscle cells , 2004, British journal of pharmacology.

[43]  John J. Wyrick,et al.  Redundant Roles for Histone H3 N-Terminal Lysine Residues in Subtelomeric Gene Repression in Saccharomyces cerevisiae , 2004, Genetics.

[44]  J. Torchia,et al.  Interaction of the HPV E7 proteins with the pCAF acetyltransferase , 2003, Oncogene.

[45]  W. Paul,et al.  In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Flavell,et al.  Cutting Edge: Changes in Histone Acetylation at the IL-4 and IFN-γ Loci Accompany Th1/Th2 Differentiation , 2002, The Journal of Immunology.

[47]  A. Hoffmann,et al.  Regulation of IL-6 and IL-8 Expression in Rheumatoid Arthritis Synovial Fibroblasts: the Dominant Role for NF-κB But Not C/EBPβ or c-Jun1 , 2000, The Journal of Immunology.

[48]  E. Androphy,et al.  AMF-1/Gps2 Binds p300 and Enhances Its Interaction with Papillomavirus E2 Proteins , 2000, Journal of Virology.

[49]  M. Lehmann,et al.  Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae , 2000, Infection and Immunity.

[50]  M. Matthay,et al.  Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. , 2000, American journal of respiratory and critical care medicine.

[51]  S. Frøland,et al.  CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes. , 2000, Cardiovascular research.

[52]  A. Hoffmann,et al.  EBP κ the Dominant Role for NF-Rheumatoid Arthritis Synovial Fibroblasts : Regulation of IL-6 and IL-8 Expression in , 2000 .

[53]  C. Allis,et al.  Overlapping but Distinct Patterns of Histone Acetylation by the Human Coactivators p300 and PCAF within Nucleosomal Substrates* , 1999, The Journal of Biological Chemistry.

[54]  P. Pavli,et al.  Interleukin 8: cells of origin in inflammatory bowel disease. , 1996, Gut.

[55]  R. Strieter,et al.  Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. , 1991, Journal of immunology.